Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LASMIDITAN vs LATANOPROST: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LASMIDITAN vs LATANOPROST: Safety Overview

Metric LASMIDITAN LATANOPROST
Total FAERS Reports 927 15,362
Deaths Reported 12 309
Death Rate 1.3% 2.0%
Hospitalizations 23 873
Average Patient Age 47.0 yrs 71.9 yrs
% Female Patients 85.4% 65.9%
FDA Approval Date Dec 18, 2020 Apr 14, 2025
Manufacturer Eli Lilly and Company Thea Pharma Inc.
Route ORAL OPHTHALMIC
Marketing Status Prescription Prescription